Malaria has developed as a serious worldwide health issue as a result of the introduction of
resistant Plasmodium species strains. Because of the common chemo resistance to most of …

Unresectable hepatocellular carcinoma (HCC) is an advanced primary liver malignancy with
a poor prognosis. The Food and Drug Administration (FDA) has, to date, approved …

Monoclonal antibodies (mAbs) are extremely specialized proteins that are cloned from B
cells and bind to pathogen epitopes. There are currently no known prophylactic immune …

Previously limited to epidemics in rural locations of central and west Africa, monkeypox
(recently renamed mpox) has been responsible for a global outbreak for the past 8 months …

Americas, 67% in the eastern Mediterranean region, and 46% in southeast Asia, including
most countries on the Indian subcontinent (Bangladesh, Bhutan, and Sri Lanka are planning …

Acknowledgements: We thank all key informants for generously sharing their expertise and
relevant data. We also thank Luca Pusceddu from Open Consultants and Jane Claire …

Full article: Monoclonal antibodies for the prevention of Plasmodium falciparum malaria: a
multi-target approach? Skip to Main Content Taylor and Francis Online homepage Taylor and …

Rodent malaria models serve as important preclinical antimalarial and vaccine testing tools.
Evaluating treatment outcomes in these models often requires manually counting parasite …

New therapeutics are a priority for preventing and eliminating Plasmodium vivax (Pv)
malaria because of its easy transmissibility and dormant stages in the liver. Relapses due to …

In The Lancet Infectious Diseases, Kirsten Lyke and colleagues1 report the findings of the
third part of a three-part trial evaluating low doses of the monoclonal antibody CIS43LS …